Octreotide Injection
342 interactions 555 cited referencesOctreotide immediate-release injection is used to decrease the amount of growth hormone (a natural substance) produced by people with acromegaly (condition in which the body produces too much growth hormone, causing enlargement of the hands, feet, and facial features; joint pain; and other symptoms) who cannot be treat… Read the full Octreotide Injection drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Major
Octreotide Injection Zanubrutinib Brukinsa Increased exposure of CYP3A4 substrates with narrow therapeutic index Details Octreotide Injection Ziftomenib Komzifti An increased risk of QT interval prolongation and torsade de pointes Details Octreotide Injection Zolmitriptan Zomig An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Octreotide Injection Zotepine An increased risk of cardiotoxicity (QT prolongation, torsade de pointes, cardiac arrest) Details Octreotide Injection Zuclopenthixol An increased risk of QT interval prolongation DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist